BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19009247)

  • 1. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
    Dinami R; Porru M; Amoreo CA; Sperduti I; Mottolese M; Buglioni S; Marinelli D; Maugeri-Saccà M; Sacconi A; Blandino G; Leonetti C; Di Rocco G; Verdina A; Spinella F; Fiorentino F; Ciliberto G; Biroccio A; Zizza P
    J Exp Clin Cancer Res; 2020 Jun; 39(1):111. PubMed ID: 32539869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients.
    Watson NF; Durrant LG; Madjd Z; Ellis IO; Scholefield JH; Spendlove I
    Cancer Immunol Immunother; 2006 Aug; 55(8):973-80. PubMed ID: 16151805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma.
    Sis B; Sarioglu S; Sokmen S; Sakar M; Kupelioglu A; Fuzun M
    J Clin Pathol; 2005 Jan; 58(1):32-8. PubMed ID: 15623479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features.
    Hotton J; Gauchotte G; Mougel R; Migliorini M; Lacomme S; Battaglia-Hsu SF; Agopiantz M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells.
    Kanzaki H; Chiba T; Kaneko T; Ao J; Kan M; Muroyama R; Nakamoto S; Kanda T; Maruyama H; Kato J; Zen Y; Kotani A; Sekiba K; Otsuka M; Ohtsuka M; Kato N
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-Binding Protein HuR in Digestive System Tumors.
    Song X; Shi X; Li W; Zhang F; Cai Z
    Biomed Res Int; 2020; 2020():9656051. PubMed ID: 32775456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
    Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
    Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Innate and Epithelial Functions of the RNA-Binding Protein HuR in Intestinal Inflammation.
    Christodoulou-Vafeiadou E; Ioakeimidis F; Andreadou M; Giagkas G; Stamatakis G; Reczko M; Samiotaki M; Papanastasiou AD; Karakasiliotis I; Kontoyiannis DL
    Front Immunol; 2018; 9():2732. PubMed ID: 30532756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Molecular Basis of Metastatic Colorectal Cancer.
    Andres SF; Williams KN; Rustgi AK
    Curr Colorectal Cancer Rep; 2018 Apr; 14(2):69-79. PubMed ID: 30237756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism.
    Basu SK; Gonit M; Salotti J; Chen J; Bhat A; Gorospe M; Viollet B; Claffey KP; Johnson PF
    Oncogene; 2018 Jun; 37(26):3528-3548. PubMed ID: 29563610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells.
    Romeo C; Weber MC; Zarei M; DeCicco D; Chand SN; Lobo AD; Winter JM; Sawicki JA; Sachs JN; Meisner-Kober N; Yeo CJ; Vadigepalli R; Tykocinski ML; Brody JR
    Mol Cancer Res; 2016 Jul; 14(7):599-611. PubMed ID: 27053682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
    Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
    Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
    Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
    Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
    Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
    ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.
    Mitra R; Zhao Z
    Int J Comput Biol Drug Des; 2014; 7(4):384-93. PubMed ID: 25539849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of HuR expression in human malignancy.
    Kotta-Loizou I; Giaginis C; Theocharis S
    Med Oncol; 2014 Sep; 31(9):161. PubMed ID: 25112469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
    Lindner R; Sullivan C; Offor O; Lezon-Geyda K; Halligan K; Fischbach N; Shah M; Bossuyt V; Schulz V; Tuck DP; Harris LN
    PLoS One; 2013; 8(11):e71915. PubMed ID: 24260093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
    Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
    Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.
    Wang J; Guo Y; Chu H; Guan Y; Bi J; Wang B
    Int J Mol Sci; 2013 May; 14(5):10015-41. PubMed ID: 23665903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.